Immunologic Control of Mus musculus Papillomavirus Type 1

• Joshua W. Wang ,

  Contributed equally to this work with: Joshua W. Wang, Rosie Jiang

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Rosie Jiang ,

  Contributed equally to this work with: Joshua W. Wang, Rosie Jiang

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Shiwen Peng,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Yung-Nien Chang,

  Affiliations Research and Development Department, Papivax LLC, Rockville, Maryland, United States of America, Immunotherapy Division, Papivax Biotech Inc., Taipei, Taiwan, Republic of China

  ⨯
• Chien-Fu Hung,

  Affiliation Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Richard B. S. Roden

  * E-mail: roden@jhmi.edu

  Affiliations Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America, Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America, Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯